Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03649152Phase 2Completed
Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan
Focal Segmental Glomerulosclerosis
PrincipalinvestigatorStart date: 2018-11-08
NCT03627715Phase 2Completed
Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan
Diabetic Kidney Disease
PrincipalinvestigatorStart date: 2018-11-06

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Renal Research

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03649152Phase 2PrincipalInvestigator

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

Focal Segmental Glomerulosclerosis
Completed
NCT03627715Phase 2PrincipalInvestigator

Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan

Diabetic Kidney Disease
Completed

All 2 trials loaded